help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism , doi:10.1210/jc.2006-2573
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nauck, M. A.
Right arrow Articles by Zapf, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nauck, M. A.
Right arrow Articles by Zapf, J.
Related Collections
Right arrow Diabetes and Insulin
Right arrow Endocrine Oncology
The Journal of Clinical Endocrinology & Metabolism Vol. 92, No. 5 1600-1605
Copyright © 2007 by The Endocrine Society


CLINICAL CASE SEMINAR

Hypoglycemia due to Paraneoplastic Secretion of Insulin-Like Growth Factor-I in a Patient with Metastasizing Large-Cell Carcinoma of the Lung

Michael A. Nauck, Manfred Reinecke, Aurel Perren, Jan Frystyk, Giorgi Berishvili, Cornelia Zwimpfer, Anja M. Figge, Allan Flyvbjerg, Paul G. Lankisch, Werner F. Blum, Günter Klöppel, Wolff Schmiegel and Jürgen Zapf

Department of Medicine (M.A.N., A.M.F., W.S.), Ruhr-University, Knappschafts-Krankenhaus, D-44892 Bochum, Germany, and Diabeteszentrum Bad Lauterberg (M.A.N.), D-37431 Bad Lauterberg im Harz, Germany; Division of Neuroendocrinology (M.R., G.B., J.Z.), Institute of Anatomy, University of Zurich, and Department of Internal Medicine (C.Z., J.Z.), University Hospital, Zurich, Switzerland; Institute of Pathology (A.P.), University Hospital, CH-8057 Zürich, Switzerland; Medical Research Laboratories (J.F., A.F.), Institute of Experimental Clinical Research, Aarhus University Hospital, DK-8000 Aarhus, Denmark; Department of Internal Medicine (P.G.L.), Städtische Kliniken D-21339 Lüneburg, Germany; Department of Pediatrics (W.F.B.), University of Giessen, Giessen, and Eli Lilly & Co., D-61350 Bad Homburg, Germany; and Department of Pathology (G.K.), Christian-Albrecht-University, D-24105 Kiel, Germany

Address all correspondence and requests for reprints to: Michael A. Nauck, M.D., Diabeteszentrum Bad Lauterberg, Kirchberg 21, D-37431 Bad Lauterberg, Germany. E-mail: M.Nauck{at}diabeteszentrum.de.

Context: Nonpancreatic tumors may cause recurrent hypoglycemia known as nonislet cell tumor hypoglycemia. It is due to overproduction and secretion by the tumor of incompletely processed IGF-II, termed big IGF-II. We recently identified a patient with recurrent hypoglycemia and low insulin, but without elevated big IGF-II. Multiple small lung nodules were detected by computed tomography scan. An undifferentiated large-cell carcinoma was diagnosed from an axillary lymph node metastasis.

Objective: The objective was to investigate whether the patient’s hypoglycemia was due to excessive IGF-I production by the tumor.

Methods: Serum IGF- I and IGF-II, insulin, and GH were measured by RIA; the distribution of IGFs between IGF binding protein complexes in serum was analyzed after neutral gel filtration. Tissue IGF-I was identified by immunohistochemistry and in situ hybridization, and by RT-PCR after RNA extraction.

Results: Total and free serum IGF-I, but not total, free, and big IGF-II, was increased, and the IGF-I content of the two IGF binding protein complexes was elevated. Immunohistochemistry demonstrated IGF-I peptide in situ hybridization IGF-I mRNA in the lymph node metastasis. Combined GH/glucocorticoid treatment prevented hypoglycemia, but did not lower IGF-I. After chemotherapy with carboplatinum/etoposide, the lung nodules largely regressed, and serum IGF-I and the IGF-I content of the two binding protein complexes became normal. Hypoglycemia did not recur despite discontinuation of GH/glucocorticoid treatment.

Conclusion: Our findings are compatible with a new form of tumor hypoglycemia caused by circulating tumor-derived IGF-I.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
P. E. Cryer, L. Axelrod, A. B. Grossman, S. R. Heller, V. M. Montori, E. R. Seaquist, and F. J. Service
Evaluation and Management of Adult Hypoglycemic Disorders: An Endocrine Society Clinical Practice Guideline
J. Clin. Endocrinol. Metab., March 1, 2009; 94(3): 709 - 728.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Respir. Crit. Care Med.Home page
A. Ashare, A. B. Nymon, K. C. Doerschug, J. M. Morrison, M. M. Monick, and G. W. Hunninghake
Insulin-like Growth Factor-1 Improves Survival in Sepsis via Enhanced Hepatic Bacterial Clearance
Am. J. Respir. Crit. Care Med., July 15, 2008; 178(2): 149 - 157.
[Abstract] [Full Text] [PDF]


Home page
Endocr Relat CancerHome page
J. W. B de Groot, B. Rikhof, J. van Doorn, H. J G Bilo, M. A Alleman, A. H Honkoop, and W. T A van der Graaf
Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases
Endocr. Relat. Cancer, December 1, 2007; 14(4): 979 - 993.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
W. H. Daughaday
Hypoglycemia due to Paraneoplastic Secretion of Insulin-Like Growth Factor-I
J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1616 - 1616.
[Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2007 by The Endocrine Society